20LBA A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
暂无分享,去创建一个
V. Hirsh | D. Henry | S. Vadhan-Raj | V. Hungria | A. Spencer | H. Yeh | S. Jun | R. Dansey | R. Moos | Jianming Wang